Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Pain
|
July 24, 2019
Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study
Alexander Hincker, Karen Frey, Lesley Rao, et al.
Journal of Gastrointestinal Oncology
|
January 5, 2018
Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer
Thomas Regenbogen, Ling Chen, Kathryn Trinkaus, et al.
Investigational New Drugs
|
December 2, 2015
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors
Manik Amin, Susan E Minton, Patricia M LoRusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2023
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy
Patrick M Grierson, Rama Suresh, Benjamin Tan, et al.
American Journal of Clinical Oncology
|
July 26, 2021
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors
Manik Amin, Feng Gao, Gretel Terrero, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2022
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors
Nusayba A Bagegni, Haeseong Park, Katlyn Kraft, et al.
Cancer Chemotherapy and Pharmacology
|
December 3, 2025
Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer
Gabriel A Brooks, Dylan B Ness, Kathryn C Hourdequin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 8, 2025
A pragmatic, single-arm clinical trial of a dose modification algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy
Heather N Wright, Tor D Tosteson, Kathryn C Hourdequin, et al.
JAMA Oncology
|
May 30, 2020
FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial
Haeseong Park, Ramon U Jin, Andrea Wang-Gillam, et al.
Clinical Colorectal Cancer
|
May 18, 2021
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial
Hyun Kim, Katrina Pedersen, Jeffrey R Olsen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Pain
|
July 24, 2019
Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study
Alexander Hincker, Karen Frey, Lesley Rao, et al.
Journal of Gastrointestinal Oncology
|
January 5, 2018
Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer
Thomas Regenbogen, Ling Chen, Kathryn Trinkaus, et al.
Investigational New Drugs
|
December 2, 2015
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors
Manik Amin, Susan E Minton, Patricia M LoRusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2023
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy
Patrick M Grierson, Rama Suresh, Benjamin Tan, et al.
American Journal of Clinical Oncology
|
July 26, 2021
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors
Manik Amin, Feng Gao, Gretel Terrero, et al.
Cancer Chemotherapy and Pharmacology
|
March 5, 2022
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors
Nusayba A Bagegni, Haeseong Park, Katlyn Kraft, et al.
Cancer Chemotherapy and Pharmacology
|
December 3, 2025
Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer
Gabriel A Brooks, Dylan B Ness, Kathryn C Hourdequin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 8, 2025
A pragmatic, single-arm clinical trial of a dose modification algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy
Heather N Wright, Tor D Tosteson, Kathryn C Hourdequin, et al.
JAMA Oncology
|
May 30, 2020
FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial
Haeseong Park, Ramon U Jin, Andrea Wang-Gillam, et al.
Clinical Colorectal Cancer
|
May 18, 2021
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial
Hyun Kim, Katrina Pedersen, Jeffrey R Olsen, et al.
Page
of 4